1.

Record Nr.

UNISANNIOPAV0007864

Titolo

Arte, storia, letteratura e religione

Pubbl/distr/stampa

Padova, : Grasso, 2009-

Lingua di pubblicazione

Non definito

Livello bibliografico

Periodico

2.

Record Nr.

UNINA9910959650703321

Titolo

Public health effectiveness of the FDA 510(k) clearance process : balancing patient safety and innovation : workshop report / / Theresa Wizemann, editor ; Committee on the Public Health Effectiveness of the FDA 510(k) clearance process, Board on Population Health and Public Health Practice, Institute of Medicine of the National Academies

Pubbl/distr/stampa

Washington, D.C., : National Academies Press, c2011

ISBN

9786613134974

9780309215114

0309215110

9781283134972

1283134977

9780309162074

0309162076

Edizione

[1st ed.]

Descrizione fisica

1 online resource (132 p.)

Altri autori (Persone)

WizemannTheresa M

Disciplina

362.1068

Soggetti

Public health - Equipment and supplies - Standards - United States

Public health - United States

Lingua di pubblicazione

Inglese

Formato

Materiale a stampa

Livello bibliografico

Monografia

Note generali

Description based upon print version of record.

Nota di bibliografia

Includes bibliographical references.

Nota di contenuto

""Front Matter""; ""Reviewers""; ""Contents""; ""Abbreviations""; ""1 Introduction""; ""2 Food and Drug Administration Postmarket Surveillance Activities and Recall Studies of Medical Devices""; ""3 Non-



Food and Drug Administration Sources of Adverse Event Data""; ""4 Postmarket Surveillance of Medical Devices: Panel Discussion""; ""5 Other Select Topics""; ""Appendix A: Workshop Agenda""; ""Appendix B: Biographic Information on Invited Speakers, Panelists, and Authors of Commissioned Papers""; ""Appendix C: 510(k) Premarket Notification Analysis of FDA Recall Data""

""Appendix D: Trustworthy Medical Device Software""

Sommario/riassunto

"The Food and Drug Administration (FDA) is responsible for ensuring that medical devices are safe and effective before they go on the market. Section 510(k) of the Federal Food, Drug, and Cosmetic Act requires a manufacturer of medical devices to notify FDA of its intent to market a medical device at least 90 days in advance. That window of time allows FDA to evaluate whether the device is substantially equivalent to a product already legally on the market (called a predicate), in which case the device does not need to go through the premarket approval (PMA) process. As part of its assessment of the FDA's premarket clearance process for medical devices, the Institute of Medicine (IOM) held a workshop on July 28, 2010 to discuss how medical devices are monitored for safety after they are available to consumers. Its primary focus was on monitoring the safety of marketed medical devices, including FDA's postmarket surveillance activities, analysis of safety concerns that resulted in medical device recalls, and non-FDA sources of adverse-event information. Public Health Effectiveness of the FDA 501(K) Clearance Process summarizes the views of the workshop participants."--Publisher's description.